Market Tracker

07/29 5:16pm ET

OPKO Health Inc (NASDAQ:OPK)

9.95
Delayed Data
As of 3:59pm ET
 +0.06 / +0.61%
Today’s Change
7.12
Today|||52-Week Range
16.90
-1.00%
Year-to-Date
Where Is the Insider Buying?
Jul 25 / TheStreet.com - Paid Partner Content
Weekly CEO Buys: Akamai, Restoration Hardware
Jul 23 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close9.89
Today’s open9.89
Day’s range9.76 - 9.96
Volume2,153,115
Average volume (3 months)3,578,367
Market cap$5.4B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+85.37%
Earnings growth (this year)-5.55%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+439.63%
P/E ratio67.9
Price/Sales9.97
Price/Book2.72

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+2.02+1.70%
ALNYAlnylam Pharmaceutic...-0.21-0.31%
TAROTaro Pharmaceutical ...+0.02+0.01%
TSROTESARO Inc-0.38-0.41%
Data as of 4:02pm ET, 07/29/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)$0.00
Annual revenue (last year)$491.7M
Annual profit (last year)-$30.0M
Net profit margin-6.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer, Treasurer, CAO &
SVP
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts